WTO Quantitative Restrictions

Singapore #9108 (v.2)

Base data

Notified in
Version validity
01/09/2024 - present
Current active version v.2
Reporting member
Singapore
In force from
End date
In force
General description
Non-automatic licence for the import of Cell, Tissue, and Gene Therapy Products
National legal basis
Health Products Act, 2007
&
Health Products (Cell, Tissue, and Gene Therapy Products) Regulations, 2021

Date of Entry into force:
1 March 2021

The latest version of the measure became effective on 18 December 2023
Administrative mechanism
The regulation of cell, tissue and gene therapy products is under the Health Products (Cell, Tissue and Gene Therapy_ Regulations 2021.

More information can be found at: https://www.hsa.gov.sg/ctgtp/dealers-licence.

Administered by HSA.
Responsible entities
Health Sciences Authority
HS version
HS 2022
Referenced WTO document symbol

Meta data

WTO justifications

XX:(b) - (b) necessary to protect human, animal or plant life or health;

GATT 1994 (GATT 1947 provisions)

Reported as: Article XX(b) of the GATT
Non-WTO commitments
Affected partners
Non-affected partners

Measures

Reported restrictions
NAL
Symbol
NAL

Tariff lines
30
Chapter 30
Cell, tissue, and gene therapy products refer to cellular-, tissue- or gene-based therapeutic produc...